Monocyte deactivation in septic patients: restoration by IFN-gamma treatment - PubMed (original) (raw)
Clinical Trial
doi: 10.1038/nm0697-678.
Affiliations
- PMID: 9176497
- DOI: 10.1038/nm0697-678
Clinical Trial
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment
W D Döcke et al. Nat Med. 1997 Jun.
Abstract
Neutralization of proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) or interleukin-1 (IL-1), decreases mortality in several animal models of sepsis. However, recent clinical trials did not show an unequivocal improvement in survival. In contrast to animals, which succumb to shock during the first 72 hours, we found that many patients die much later with signs of opportunistic infections accompanied by downregulation of their monocytic HLA-DR expression and reduced ability to produce lipopolysaccharide (LPS)-induced TNF-alpha in vitro. This phenomenon of monocyte deactivation in septic patients with fatal outcome shows similarities to experimental monocytic refractoriness induced by LPS desensitization or by pretreatment with its endogenous mediators IL-10 and transforming growth factor-beta (TGF-beta). In order to strengthen their antimicrobial defense, here we tested whether interferon-gamma (IFN-gamma) can improve monocytic functions in these patients and in experimental monocytic deactivation. The considerably lowered in vitro levels of LPS-induced TNF-alpha in these situations were significantly enhanced by IFN-gamma, but did not reach the extremely high levels of IFN-gamma primed naive cells from healthy donors. Moreover, IFN-gamma applied to septic patients with low monocytic HLA-DR expression restored the deficient HLA-DR expression and in vitro LPS-induced TNF-alpha secretion. Recovery of monocyte function resulted in clearance of sepsis in eight of nine patients. These data suggest that IFN-gamma treatment in carefully selected septic patients is a novel therapeutic strategy worth pursuing.
Similar articles
- Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro.
Kylanpaa ML, Mentula P, Kemppainen E, Puolakkainen P, Aittomaki S, Silvennoinen O, Haapiainen R, Repo H. Kylanpaa ML, et al. Pancreas. 2005 Jul;31(1):23-7. doi: 10.1097/01.mpa.0000164449.23524.94. Pancreas. 2005. PMID: 15968243 - In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor.
Randow F, Döcke WD, Bundschuh DS, Hartung T, Wendel A, Volk HD. Randow F, et al. J Immunol. 1997 Mar 15;158(6):2911-8. J Immunol. 1997. PMID: 9058829 - Monocyte deactivation--rationale for a new therapeutic strategy in sepsis.
Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Müller JM, Döcke WD, Kox WJ. Volk HD, et al. Intensive Care Med. 1996 Oct;22 Suppl 4:S474-81. doi: 10.1007/BF01743727. Intensive Care Med. 1996. PMID: 8923092 Review. - Immunomodulatory therapies in sepsis.
Kox WJ, Volk T, Kox SN, Volk HD. Kox WJ, et al. Intensive Care Med. 2000;26 Suppl 1:S124-8. doi: 10.1007/s001340051129. Intensive Care Med. 2000. PMID: 10786969 Review.
Cited by
- Damping excessive viral-induced IFN-γ rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis.
Seldeslachts L, Staels F, Gkountzinopoulou M, Jacobs C, Tielemans B, Vanhoffelen E, Reséndiz-Sharpe A, De Herdt L, Haughton J, Prezzemolo T, Burton O, Feys S, van de Veerdonk FL, Carvalho A, Naesens L, Matthys P, Lagrou K, Verbeken E, Chamilos G, Wauters J, Humblet-Baron S, Vande Velde G. Seldeslachts L, et al. EBioMedicine. 2024 Oct;108:105347. doi: 10.1016/j.ebiom.2024.105347. Epub 2024 Sep 30. EBioMedicine. 2024. PMID: 39353282 Free PMC article. - IL-33 in Ischemic Stroke: Brain vs. Periphery.
Mathias K, Machado RS, Tiscoski ADB, Dos Santos D, Lippert FW, Costa MA, Gonçalves CL, Generoso JS, Prophiro JS, Giustina AD, Petronilho F. Mathias K, et al. Inflammation. 2024 Sep 19. doi: 10.1007/s10753-024-02148-6. Online ahead of print. Inflammation. 2024. PMID: 39294293 Review. - The role of trained immunity in sepsis.
Wang W, Ma L, Liu B, Ouyang L. Wang W, et al. Front Immunol. 2024 Aug 15;15:1449986. doi: 10.3389/fimmu.2024.1449986. eCollection 2024. Front Immunol. 2024. PMID: 39221248 Free PMC article. Review. - Infection, inflammation and hepatic encephalopathy from a clinical perspective.
Ntuli Y, Shawcross DL. Ntuli Y, et al. Metab Brain Dis. 2024 Aug 30. doi: 10.1007/s11011-024-01402-y. Online ahead of print. Metab Brain Dis. 2024. PMID: 39212845 Review. - Evolving Paradigms in Sepsis Management: A Narrative Review.
Kim MJ, Choi EJ, Choi EJ. Kim MJ, et al. Cells. 2024 Jul 9;13(14):1172. doi: 10.3390/cells13141172. Cells. 2024. PMID: 39056754 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials